Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Neoadjuvant chemotherapy (NACT) is offered to an increasing number of breast cancer (BC) patients, and comprehensive monitoring of treatment response is of utmost importance. Several imaging modalities are available to follow tumor response, although likely to provide different clinical information. We aimed to examine the association between early radiological response by three conventional imaging modalities and pathological complete response (pCR). Further, we investigated the agreement between these modalities pre-, during, and post-NACT, and the accuracy of predicting pathological residual tumor burden by these imaging modalities post-NACT.

Detaljer

Författare
Enheter & grupper
Externa organisationer
  • Aarhus University Hospital
  • Aarhus University
  • Skåne University Hospital
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Cancer och onkologi
Originalspråkengelska
Sidor (från-till)1528-1537
Antal sidor10
TidskriftActa Oncologica
Volym59
Utgåva nummer12
Tidigt onlinedatum2020 okt 16
StatusPublished - 2020
PublikationskategoriForskning
Peer review utfördJa

Relaterad forskningsoutput

Ida Dalene Skarping, 2020, Lund: Lund University, Faculty of Medicine. 134 s.

Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

Visa alla (1)